Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2023 | Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial | Heo, Jeong; JA-DER LIANG ; Kim, Chang Won; Woo, Hyun Young; I-LUN SHIH ; TUNG-HUNG SU ; ZHONG-ZHE LIN ; Yoo, So Young; Chang, Stanley; Urata, Yasuo; PEI-JER CHEN | Molecular therapy : the journal of the American Society of Gene Therapy | 3 | 1 | |
2004 | SARS exposure and emergency department workers | WEI-TIEN CHANG ; CHUAN-LIANG KAO ; Chung M.-Y.; SHYR-CHYR CHEN ; Lin S.-J.; WEN-CHU CHIANG ; SHEY-YING CHEN ; Su C.-P.; PO-REN HSUEH ; WEN-JONE CHEN ; PEI-JER CHEN ; PAN-CHYR YANG | Emerging Infectious Diseases | 28 | 24 | |
2004 | SARS in Hospital Emergency Room | YEE-CHUN CHEN ; LI-MIN HUANG ; CHANG-CHUAN CHAN ; Su C.-P.; SHAN-CHWEN CHANG ; Chang Y.-Y.; Chen M.-L.; CHIEN-CHING HUNG ; WEN-JONE CHEN ; Lin F.-Y.; Lee Y.-T.; DING-SHINN CHEN ; Lee Y.-T.; Teng C.-M.; PAN-CHYR YANG ; HONG-NERNG HO ; PEI-JER CHEN ; MING-FU CHANG ; JIN-TOWN WANG ; CHUAN-LIANG KAO ; Wang W.-K.; Hsiao C.-H.; PO-REN HSUEH | Emerging Infectious Diseases | 122 | 116 | |
2014 | SC-60, a dimer-based sorafenib derivative, shows a better anti-hepatocellular carcinoma effect than sorafenib in a preclinical hepatocellular carcinoma model | Tai W.-T.; Shiau C.-W.; Li Y.-S.; Chen Y.-L.; Chu P.-Y.; Huang J.-W.; Hsu C.-Y.; Hsu Y.-C.; PEI-JER CHEN ; Chen K.-F. | Molecular Cancer Therapeutics | 7 | 6 | |
2020 | Secular Trends and Geographic Maps of Hepatitis C Virus Infection among 4 Million Blood Donors in Taiwan from 1999 to 2017 | Chen Y.-Y.; CHI-LING CHEN ; Chen J.-W.; Hsu N.-T.; Wei S.-T.; Hou S.-M.; Lu S.-N.; PEI-JER CHEN | Hepatology Communications | 12 | 11 | |
2013 | Selenium for sepsis: What have we learned so far? | Huang T.-S.; Shyu Y.-C.; Yuan S.-S.; PEI-JER CHEN | Critical Care Medicine | 0 | 0 | |
2003 | SEN virus infection in patients with chronic hepatitis C: Preferential coinfection with hepatitis C genotype 2a and no effect on response to therapy with interferon plus ribavirin | JIA-HORNG KAO ; Chen W.; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Infectious Diseases | 22 | 20 | |
2002 | Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Medical Virology | 41 | 34 | |
2024 | Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results | Qin, Albert; Wu, Chang-Ru; MING-CHIH HO ; Tsai, Chan-Yen; PEI-JER CHEN | International journal of molecular sciences | 1 | | |
2023 | Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 months | TUNG-HUNG SU ; Chang, Shan-Han; CHI-LING CHEN ; SIH-HAN LIAO ; TAI-CHUNG TSENG ; SHIH-JER HSU ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Hepatology research : the official journal of the Japan Society of Hepatology | 1 | 0 | |
2013 | Seroprevalence of Hepatitis E Virus Infection among Swine Farmers and the General Population in Rural Taiwan | JIAN-TE LEE ; PEI-LAN SHAO ; LUAN-YIN CHANG ; Xia N.-S.; PEI-JER CHEN ; CHUN-YI LU ; LI-MIN HUANG | PLoS ONE | 22 | 13 | |
1996 | Serotypes, genotypes and levels of hepatitis C viremia in pregnant women in Taiwan | HO-HSIUNG LIN ; JIA-HORNG KAO ; Mizokami M.; Huang S.-C.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 5 | 3 | |
1996 | Serotyping of hepatitis C virus in chronic type C hepatitis in Taiwan: Correlation with genotypes | JIA-HORNG KAO ; HO-HSIUNG LIN ; PEI-JER CHEN ; Lai M.-Y.; Wang T.-H.; Mizokami M.; DING-SHINN CHEN | Journal of Gastroenterology | 16 | 16 | |
2005 | Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C | CHUN-JEN LIU ; PEI-JER CHEN ; YUNG-MING JENG ; Huang W.-L.; WEI-SHIUNG YANG ; Lai M.-Y.; JIA-HORNG KAO ; DING-SHINN CHEN | Journal of Hepatology | 67 | 59 | |
2023 | Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy | Lin, Meng-Ju; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; CHI-LING CHEN ; JYH-MING LIOU ; TAI-CHUNG TSENG ; CHEN-HUA LIU ; CHUN-MING HONG ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 1 | |
2014 | Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications | Wu H.-L.; JIA-HORNG KAO ; Chen T.-C; Wu W.-H; CHEN-HUA LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; DING-SHINN CHEN ; PEI-JER CHEN ; CHUN-JEN LIU | Journal of Gastroenterology and Hepatology (Australia) | 28 | 24 | |
2022 | Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents | SHANG-CHIN HUANG ; Cheng, Pin-Nan; CHEN-HUA LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO ; CHUN-JEN LIU | Journal of the Formosan Medical Association = Taiwan yi zhi | 8 | 11 | |
2021 | Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Yang W.-T; Hsu C.-Y; CHUN-MING HONG ; TUNG-HUNG SU ; Tsai C.-H; CHI-LING CHEN ; HUNG-CHIH YANG ; CHEN-HUA LIU ; Chen, Tony Hsiu Hsi ; PEI-JER CHEN ; JIA-HORNG KAO | Alimentary Pharmacology and Therapeutics | 14 | 15 | |
2010 | Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B | TUNG-HUNG SU ; Hsu C.-S.; CHI-LING CHEN ; CHEN-HUA LIU ; Huang Y.-W.; TAI-CHUNG TSENG ; CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN ; JIA-HORNG KAO | Antiviral Therapy | 78 | 73 | |
2013 | Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Hsu C.-A; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Hepatology | 218 | 195 | |